MedPath

Sleep disruption in quadriplegia – A pilot study exploring whether 3mg melatonin induces sleep

Phase 4
Completed
Conditions
nrefreshing sleep
Unrefreshing sleep
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12608000504314
Lead Sponsor
Austin Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
5
Inclusion Criteria

Complete (motor and sensory) quadriplegia (T1 or higher lesion)

Exclusion Criteria

Major psychological or psychiatric disturbances, Neurological damage other than spinal cord injury, Other significant co-morbidity, Beta blockers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath